カテゴリー： QYResearch, 世界

世界の高性能医薬品有効成分(HPAPI)市場 2019年

【英語タイトル】Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09035）・商品コード：DATA909X09035
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、高性能医薬品有効成分(HPAPI)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、合成成分、生物学的成分、その他に、用途別には、腫瘍学、緑内障、抗糖尿病、心血管、筋骨格、ホルモン、その他にセグメント区分し、高性能医薬品有効成分(HPAPI)の世界市場を分析しました。


・エグゼクティブ・サマリー
・高性能医薬品有効成分(HPAPI)の世界市場概要
・高性能医薬品有効成分(HPAPI)の製造コスト構成分析
・高性能医薬品有効成分(HPAPI)の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・高性能医薬品有効成分(HPAPI)の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・高性能医薬品有効成分(HPAPI)のセグメント分析（種類別）
（合成成分、生物学的成分、その他）
・高性能医薬品有効成分(HPAPI)のセグメント分析（用途別）
（腫瘍学、緑内障、抗糖尿病、心血管、筋骨格、ホルモン、その他）
・高性能医薬品有効成分(HPAPI)の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bristol-Myers Squibb、Novartis、Sanofi Aventis、Pfizer、Lonza、Novasep、Hospira、BASF、Merck、Bayer、Teva Pharmaceuticals、Boehringer Ingelheim、）
・高性能医薬品有効成分(HPAPI)の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global High Performance Active Pharmaceutical Ingredients (HPAPI) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on High Performance Active Pharmaceutical Ingredients (HPAPI) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Performance Active Pharmaceutical Ingredients (HPAPI) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of High Performance Active Pharmaceutical Ingredients (HPAPI) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their High Performance Active Pharmaceutical Ingredients (HPAPI) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bristol-Myers Squibb
Novartis
Sanofi Aventis
Pfizer
Lonza
Novasep
Hospira
BASF
Merck
Bayer
Teva Pharmaceuticals
Boehringer Ingelheim

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Synthetic Ingredients
Biological Ingredients
Others

Segment by Application
Oncology
Glaucoma
Anti-diabetic
Cardiovascular
Musculoskeletal
Hormonal
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of High Performance Active Pharmaceutical Ingredients (HPAPI)
1.1 Definition of High Performance Active Pharmaceutical Ingredients (HPAPI)
1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Type
1.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Synthetic Ingredients
1.2.3 Biological Ingredients
1.2.4 Others
1.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Applications
1.3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Glaucoma
1.3.4 Anti-diabetic
1.3.5 Cardiovascular
1.3.6 Musculoskeletal
1.3.7 Hormonal
1.3.8 Others
1.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Overall Market
1.4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (2014-2025)
1.4.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (2014-2025)
1.4.3 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.5 China High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.6 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.7 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.8 India High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
2.3 Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
2.4 Industry Chain Structure of High Performance Active Pharmaceutical Ingredients (HPAPI)

3 Development and Manufacturing Plants Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
3.1 Capacity and Commercial Production Date
3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of High Performance Active Pharmaceutical Ingredients (HPAPI)
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Production and Capacity Analysis
4.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Analysis
4.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Price Analysis
4.4 Market Concentration Degree

5 High Performance Active Pharmaceutical Ingredients (HPAPI) Regional Market Analysis
5.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Regions
5.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Regions
5.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Regions
5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Regions
5.3 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.3.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.3.2 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.4.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.4.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.5 China High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.5.1 China High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.5.2 China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.6 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.6.1 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.6.2 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.7 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.7.1 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.7.2 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.8 India High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.8.1 India High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.8.2 India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export

6 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment Market Analysis (by Type)
6.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Type
6.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Type
6.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Price by Type

7 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment Market Analysis (by Application)
7.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Application
7.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Application (2014-2019)

8 High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers Analysis
8.1 Bristol-Myers Squibb
8.1.1 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.1.3 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi Aventis
8.3.1 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.3.2 Sanofi Aventis Product Introduction, Application and Specification
8.3.3 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Lonza
8.5.1 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.5.2 Lonza Product Introduction, Application and Specification
8.5.3 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novasep
8.6.1 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.6.2 Novasep Product Introduction, Application and Specification
8.6.3 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Hospira
8.7.1 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.7.2 Hospira Product Introduction, Application and Specification
8.7.3 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 BASF
8.8.1 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.8.2 BASF Product Introduction, Application and Specification
8.8.3 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Merck
8.9.1 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.9.2 Merck Product Introduction, Application and Specification
8.9.3 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Bayer
8.10.1 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.10.2 Bayer Product Introduction, Application and Specification
8.10.3 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Teva Pharmaceuticals
8.12 Boehringer Ingelheim

9 Development Trend of Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI) Market
9.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Trend Analysis
9.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Volume and Value) Forecast 2019-2025
9.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Regional Market Trend
9.2.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.5 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.6 India High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Trend (Product Type)
9.4 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of High Performance Active Pharmaceutical Ingredients (HPAPI)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Types in 2018
Figure Synthetic Ingredients Product Picture
Figure Biological Ingredients Product Picture
Figure Others Product Picture
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Applications in 2018
Figure Oncology
Figure Glaucoma
Figure Anti-diabetic
Figure Cardiovascular
Figure Musculoskeletal
Figure Hormonal
Figure Others
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) (2014-2025)
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) (2014-2025)
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI) in 2018
Figure Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
Figure Industry Chain Structure of High Performance Active Pharmaceutical Ingredients (HPAPI)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Plants Distribution
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity (K MT) of Major Manufacturers (2014-2019)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) of Major Manufacturers (2014-2019)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share of Major Manufacturers (2014-2019)
Figure High Performance Active Pharmaceutical Ingredients (HPAPI) Production Share by Manufacturers in 2018
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share of Major Manufacturers (2014-2019)
Figure High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Manufacturers in 2018
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Regions 2014-2019 (K MT)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Regions 2014-2019
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Regions in 2018
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Regions 2014-2019 (Million USD)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Regions 2014-2019
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Regions in 2018
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Regions 2014-2019 (K MT)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Regions 2014-2019
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Global Consumption High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2014-2019)
Figure Global Value (Consumption) High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) Growth Rate Forecast 2019-2025
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Forecast 2019-2025
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of High Performance Active Pharmaceutical Ingredients (HPAPI) by Type (2019-2025)
Table Global Consumption (K MT) of High Performance Active Pharmaceutical Ingredients (HPAPI) by Application (2019-2025)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Distributors List
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bristol-Myers Squibb、Novartis、Sanofi Aventis、Pfizer、Lonza、Novasep、Hospira、BASF、Merck、Bayer、Teva Pharmaceuticals、Boehringer Ingelheim、

★調査レポート[世界の高性能医薬品有効成分(HPAPI)市場 2019年] (コード：DATA909X09035)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の高性能医薬品有効成分(HPAPI)市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヘパリン有効成分市場 2019年
    DATA909X08952 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヘパリン有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヘパリンナトリウム、ヘパリンカルシウム、その他に、用途別には、UFH、LMWHにセグメント区分し、ヘパリン有効成分の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヘパリン有効成分の世界市場概要 ・ヘパリン有効成分の製造コスト構成分析 ・ヘパリン有効成分の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヘパリン有効成分の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヘパリン有効成分のセグメント分析（種類別） （ヘパリンナトリウム、ヘパリンカルシウム、その他）...The global Heparin Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Heparin Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の特殊な有効成分産業：成長傾向・競合分析2019-2025
    DATA909X02219 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の特殊な有効成分市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。特殊な有効成分の種類別には、ステロイドAPI、ペプチドAPI、炭水化物API、小分子API、高効能APに、用途別には、CNS、心血管、泌尿生殖器/ホルモン薬、リウマチ、糖尿病、腫瘍学、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・特殊な有効成分の種類別市場規模：ステロイドAPI、ペプチドAPI、炭水化物API、小分子API、高効能AP ・特殊な有効成分の用途別市場規模：CNS、心血管、泌尿生殖器/ホルモン薬、リウマチ、糖尿病、腫瘍学、その他 ・特殊な有効成分の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Sanofi、Cambrex、Almac、Johnson Matthey、PolyPeptide、AmbioPharm、Avecia、ST Pharm、Biospring...Special active pharmaceutical ingredients are bioactive chemicals used as intermediate components in pharmaceutical manufacturing, such as tablets, capsules, syrups, etc.Special active pharmaceutical ingredients include steroidal API, peptide, carbohydrate API, small molecule and high efficiency API.In 2018, the global Specialty Active Pharmaceutical Ingredients market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Specialty Active Pharmaceutical Ingredients. This study researches the market size...
  • 世界のデュロキセチン医薬品有効成分（API）産業：成長傾向・競合分析2019-2025
    DATA909X00751 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のデュロキセチン医薬品有効成分（API）市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。デュロキセチン医薬品有効成分（API）の種類別には、大うつ薬、全身性不安障害薬、線維筋痛薬、神経障害性疼痛治療​​薬、その他に、用途別には、製薬及びバイオテクノロジー産業、病院、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・デュロキセチン医薬品有効成分（API）の種類別市場規模：大うつ薬、全身性不安障害薬、線維筋痛薬、神経障害性疼痛治療​​薬、その他 ・デュロキセチン医薬品有効成分（API）の用途別市場規模：製薬及びバイオテクノロジー産業、病院、その他 ・デュロキセチン医薬品有効成分（API）の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Teva Pharmaceutical Industries...Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical formulations. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Moreover, it is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia.In 2018, the global Duloxetine Active Pharmaceutical Ingredients (API) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025...
  • 世界の化粧品の有効成分市場 2019年
    DATA909X06050 / QYResearch / 2019年11月15日 / ※本調査レポートは、化粧品の有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、非処方薬有効成分、機能性成分に、用途別には、スキンケア、ヘアケアにセグメント区分し、化粧品の有効成分の世界市場を分析しました。 ・エグゼクティブ・サマリー ・化粧品の有効成分の世界市場概要 ・化粧品の有効成分の製造コスト構成分析 ・化粧品の有効成分の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・化粧品の有効成分の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・化粧品の有効成分のセグメント分析（種類別） （非処方薬有効成分、機能性成分）...The global Cosmetic Active Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cosmetic Active Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cosmetic Active Ingredients market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cosmetic Active Ingredients in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 医薬品における高速液体クロマトグラフ（HPLC）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103434 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、医薬品における高速液体クロマトグラフ（HPLC）の世界市場について調べ、まとめました。種類別セグメントは、ポンプ、インジェクター、検出器等、用途別セグメントは、製薬会社、研究機関、研究機関、その他等に区分しました。医薬品における高速液体クロマトグラフ（HPLC）の世界市場概観、企業動向、企業別医薬品における高速液体クロマトグラフ（HPLC）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・医薬品における高速液体クロマトグラフ（HPLC）の市場概観 ・医薬品における高速液体クロマトグラフ（HPLC）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・医薬品における高速液体クロマトグラフ（HPLC）の企業別販売動向、市場シェア、市場集中度、競争動向 ・医薬品における高速液体クロマトグラフ（HPLC）の世界市場規模 ・医薬品における高速液体クロマトグラフ（HPLC）の北米市場分析（アメリカ、カナダ、メキシコ等） ・医薬品における高速液体クロマトグラフ（HPLC）のアメリカ市場規模推移 ・医薬品における高速液体クロマトグラフ（HPLC）のカナダ市場規模推移 ・医薬品における高速液体クロマトグラフ（HPLC）のメキシコ市場規模推移 ・医薬品における高速液体クロマトグラフ（HPLC）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...HPLC is a separation technique in which liquid is used to force the sample at high pressure through a column packed with stationary phase in order to identify and quantify the components. Scope of the Report: The global High-Performance Liquid Chromatography (HPLC) in Pharmaceutical market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America,...
  • 世界の高性能ドア市場 2019年
    DATA909X09038 / QYResearch / 2019年11月20日 / ※本調査レポートは、高性能ドアの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ローリングドア、フォールディングドア、スライドドア、スイングドア、その他に、用途別には、大規模外部開口部、医薬品環境、食品及び飲料産業、倉庫及び荷積湾、その他にセグメント区分し、高性能ドアの世界市場を分析しました。 ・エグゼクティブ・サマリー ・高性能ドアの世界市場概要 ・高性能ドアの製造コスト構成分析 ・高性能ドアの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・高性能ドアの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・高性能ドアのセグメント分析（種類別） （ローリングドア、フォールディングドア、スライドドア、スイングドア、その他）...The global High Performance Door market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Performance Door volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Performance Door market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of High Performance Door in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のインスリン有効成分市場 2019年
    DATA909X09919 / QYResearch / 2019年11月20日 / ※本調査レポートは、インスリン有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、化学合成、動物エキスに、用途別には、動物インスリン、一般ヒトインスリン、インスリンアナログにセグメント区分し、インスリン有効成分の世界市場を分析しました。 ・エグゼクティブ・サマリー ・インスリン有効成分の世界市場概要 ・インスリン有効成分の製造コスト構成分析 ・インスリン有効成分の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・インスリン有効成分の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・インスリン有効成分のセグメント分析（種類別） （化学合成、動物エキス）...The global Insulin Active Pharmaceutical Ingredient market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Insulin Active Pharmaceutical Ingredient volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Active Pharmaceutical Ingredient market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Active Pharmaceutical Ingredient in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の特殊フィルムおよび高性能フィルム市場 2019年
    DATA909X15649 / QYResearch / 2019年11月20日 / ※本調査レポートは、特殊フィルムおよび高性能フィルムの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、特殊フィルム、高性能フィルムに、用途別には、バリアフィルム、装飾フィルム、微孔性フィルム、安全およびセキュリティフィルムにセグメント区分し、特殊フィルムおよび高性能フィルムの世界市場を分析しました。 ・エグゼクティブ・サマリー ・特殊フィルムおよび高性能フィルムの世界市場概要 ・特殊フィルムおよび高性能フィルムの製造コスト構成分析 ・特殊フィルムおよび高性能フィルムの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・特殊フィルムおよび高性能フィルムの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・特殊フィルムおよび高性能フィルムのセグメント分析（種類別） （特殊フィルム、高性能フィルム）...The global Specialty and High-performance Films market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Specialty and High-performance Films volume and value at global level, regional level and company level. From a global perspective, this report represents overall Specialty and High-performance Films market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Specialty and High-performance Films in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆